Sangamo BioSciences Provides Clinical Update on SB-728-T Program and Progress in Other ZFP Applications at Annual Meeting of the American Society of Gene and Cell Therapy /PRNewswire/ -- Sangamo BioSciences, Inc. announced that data from clinical, preclinical and research-stage programs focused on the development of ZFP Therapeutics were outlined ... (more)
http://ift.tt/RwKkUg
http://ift.tt/RwKkUg
No comments:
Post a Comment